Lesion Detection and Interobserver Agreement with Advanced Image Reconstruction for


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
02 2020
Historique:
received: 05 11 2019
accepted: 13 08 2019
pubmed: 5 9 2019
medline: 25 7 2020
entrez: 5 9 2019
Statut: ppublish

Résumé

Biochemically recurrent prostate cancer (BCR) is the main indication to perform prostate-specific membrane antigen PET/CT. However, localizing BCR with prostate-specific membrane antigen PET/CT remains challenging in patients with low prostate-specific antigen (PSA) values. Here, we studied the impact of advanced PET image reconstruction methods on BCR localization and interobserver agreement with

Identifiants

pubmed: 31481580
pii: jnumed.118.222513
doi: 10.2967/jnumed.118.222513
doi:

Substances chimiques

2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 0
Urea 8W8T17847W
Lysine K3Z4F929H6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

210-216

Informations de copyright

© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Bernard H E Jansen (BHE)

Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Robin W Jansen (RW)

Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Maurits Wondergem (M)

Department of Radiology and Nuclear Medicine, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands.

Sandra Srbljin (S)

Department of Nuclear Medicine, Zaans Medisch Centrum, Zaandam, The Netherlands.

John M H de Klerk (JMH)

Department of Radiology and Nuclear Medicine, Meander Medisch Centrum, Amersfoort, The Netherlands; and.

Birgit I Lissenberg-Witte (BI)

Department of Epidemiology and Biostatistics, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

André N Vis (AN)

Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Reindert J A van Moorselaar (RJA)

Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Ronald Boellaard (R)

Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Otto S Hoekstra (OS)

Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Daniela E Oprea-Lager (DE)

Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands d.oprea-lager@vumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH